This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Permanently Discontinued

RAN-AMLODIPINE

RANBAXY PHARMACEUTICALS CANADA INC.

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of RAN-AMLODIPINE in Canada?

Yes. RAN-AMLODIPINE 5MG has an active shortage reported to Health Canada (last updated November 11, 2025).

Why is RAN-AMLODIPINE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will RAN-AMLODIPINE be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength5MG

Report last updated2020-05-14

Checked by MedShort2026-11-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

JAMP-AMLODIPINE

JAMP PHARMA CORPORATION

5MG · DIN 02357194

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

TEVA-AMLODIPINE

TEVA CANADA LIMITED

5MG · DIN 02297485

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

APO-AMLODIPINE

APOTEX INC

5MG · DIN 02273373

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

PMS-AMLODIPINE

PHARMASCIENCE INC

5MG · DIN 02284065

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

NORVASC

BGP PHARMA ULC

10MG · DIN 00878936

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

MYLAN-AMLODIPINE

MYLAN PHARMACEUTICALS ULC

10.0MG · DIN 02272121

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02321858

Strength

5MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

AMLODIPINE

Tier

Unrated

Last Updated

2020-05-14

Reason for Shortage

Manufacturing issues

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

RAN-AMLODIPINE has 3 shortage/discontinuation reports on file — this is one of them.

2025-11-11

Active Shortage

Disruption of the manufacture of the drug.

2020-05-14

Permanently Discontinued

Manufacturing issues

Other Products from RANBAXY PHARMACEUTICALS CANADA INC.

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

RAN-CITALO

40MG · DIN 02285630

RAN-CITALO

20MG · DIN 02285622

RAN-FENTANYL MATRIX PATCH

75MCG · DIN 02330148

RAN-FENTANYL MATRIX PATCH

100MCG · DIN 02330156

RAN-FENTANYL MATRIX PATCH

12MCG · DIN 02330105

RAN-FENTANYL MATRIX PATCH

50MCG · DIN 02330121